Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.70
-1.08 (-3.02%)
Aug 11, 2026, 10:53 AM EDT - Market open

Roivant Sciences Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
7.538.2629.0532.7161.2855.29
Revenue Growth
-67.58%-71.57%-11.19%-46.62%10.84%132.34%
Gross Profit
-1.426.9828.1431.1148.1546.32
Operating Income
-596.14-515.07-1,0034,497-1,175-1,352
Net Income
-266.25-299.77-171.984,349-1,009-845.26
Earnings Per Share
-0.53-0.54-0.245.23-1.42-1.26
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
3,8424,2924,8876,4951,6772,060
Total Debt
107.15107.44100.1753.99481.4283.89
Net Cash (Debt)
3,7354,1844,7876,4411,1951,777
Net Cash Growth
-15.18%-12.58%-25.68%438.81%-32.71%-1.85%
Net Cash Per Share
5.136.036.607.751.682.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-816.47-750.35-839.45-765.27-843.39-677.73
Capital Expenditures
-4.59-8.21-4.6-1.38-12.69-17.44
Free Cash Flow
-821.06-758.56-844.05-766.65-856.08-695.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
-18.79%84.44%96.86%95.11%78.58%83.78%
Operating Margin
-7914.75%-6235.69%-3453.32%13746.90%-1917.95%-2444.82%
Pretax Margin
-3848.65%-3203.12%-2346.02%13963.43%-1998.75%-1670.85%
Profit Margin
-5504.54%-4817.28%-2511.84%13897.70%-2007.22%-1671.52%
FCF Margin
-10901.00%-9183.51%-2905.21%-2343.56%-1397.00%-1257.40%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
---2.02--
PS Ratio
3431.322415.71241.70259.9191.5462.10